AMRX

Amneal Pharmaceuticals Stock Price

5.96
-0.06 (-1.0%)
Upgrade to Real-Time
Afterhours (Closed)
5.96

Low
3.45

52 Week Range

High
7.445

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Amneal Pharmaceuticals Inc AMRX NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.06 -1.0% 5.96 20:00:00
Open Price Low Price High Price Close Price Prev Close
6.03 5.95 6.09 5.96 6.02
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,544 429,116 $ 6.01 $ 2,580,700 860,163 3.45 - 7.445
Last Trade Time Type Quantity Stock Price Currency
19:00:00 59,156 $ 5.96 USD

Amneal Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 886.37M 148.72M 98.90M $ 1.99B $ -43.64M 0.62 -49.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 3.69M 2.10%

more financials information »

Amneal Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AMRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.586.215.455.79776,0460.386.81%
1 Month5.526.215.455.70627,2800.447.97%
3 Months7.007.4455.146.061,072,165-1.04-14.86%
6 Months4.157.4454.015.581,514,3881.8143.61%
1 Year4.887.4453.455.071,356,7481.0822.13%
3 Years19.0624.482.277.081,529,110-13.10-68.73%
5 Years17.0024.482.277.331,521,185-11.04-64.94%

Amneal Pharmaceuticals Description

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies.


Your Recent History
NYSE
AMRX
Amneal Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.